CL vs SPRB · P/E 34, rev $20.38B vs rev $4.9M
Colgate-Palmolive Company (CL) versus Spruce Biosciences Inc (SPRB) — a side-by-side from cached financials, not a winner call.
Colgate-Palmolive Company (CL) is a household & personal products company listed on US.
Spruce Biosciences Inc (SPRB) is a biotechnology company listed on US.
Latest reported CL revenue for 2025-12-31 was $20.38B. Net income was $2.13B. Revenue was up 1.4% from 2024-12-31 to 2025-12-31. CL currently screens at market cap $70.88B and trailing P/E 34.3.
Latest reported SPRB revenue for 2024-12-31 was $4.9M. Net income was -$53.0M. Revenue was down 51.3% from 2023-12-31 to 2024-12-31. SPRB currently screens at market cap $3.0M.
CL currently screens at market cap $70.88B and trailing P/E 34.3. SPRB currently screens at market cap $3.0M.
Not investment advice. Open the CL and SPRB stock pages for the full models.
Not investment advice.